PERSONALISING COVID RISK
Personalising risk from COVID-19 key to protecting immunosuppressed people
New research underscores the need for ongoing COVID-19 protection for people with weakened immune systems.
Stories written by Lou Lee
News in brief
Brain disease genes, ecology elections and Martian rocks: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Imperial excellence
Imperial academics elected to Academy of Medical Sciences Council
Three Imperial College London academics have been elected to the Council of the prestigious Academy of Medical Sciences.
Tackling AMR
Meet the Imperial experts fighting bacterial resistance through innovation
Professor Shiranee Sriskandan and Dr Andrew Edwards shed light on the vital work of Imperial’s Centre for Bacterial Resistance Biology (CBRB).
Viral Hepatitis
Tackling the global burden of hepatitis
On World Hepatitis Day, Imperial experts push for urgent elimination of viral hepatitis.
AMR SOLUTIONS
Imperial-led network to tackle AMR and fungal disease with new UKRI funding
An Imperial-led project aims to advance our knowledge of the underlying drivers of drug-resistant fungal infections and develop countermeasures.
HUMAN CHALLENGE STUDIES
HIC-Vac: Improving vaccine development through human challenge studies
Professor Peter Openshaw explains how HIC-Vac is developing human challenge studies to improve vaccines against major infections.
RESEARCH COLLABORATION
LKCMedicine visits Imperial to explore new research opportunities
Imperial and LKCMedicine are exploring new opportunities for collaboration in medical research as they enter the next phase of their partnership.
T CELL RESPONSES
T cells may provide more durable protection against Omicron than antibodies
New review suggests T cells are more robust against ‘Omicron breakthroughs’ than antibodies, offering fresh insights for COVID-19 vaccine development.
Neglected diseases
Fighting neglected tropical diseases
To mark World Neglected Tropical Diseases Day, we explore how Imperial scientists are combatting these diseases that affect millions each year.
